United States. Congress. House. Committee on Oversight and Reform. (2022). The firm and the FDA: McKinsey & Company's conflicts of interest at the heart of the opioid epidemic : interim majority staff report. Committee on Oversight and Reform, U.S. House of Representatives.
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Oversight and Reform. The Firm and the FDA: McKinsey & Company's Conflicts of Interest at the Heart of the Opioid Epidemic : Interim Majority Staff Report. [Washington, D.C.]: Committee on Oversight and Reform, U.S. House of Representatives, 2022.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Oversight and Reform. The Firm and the FDA: McKinsey & Company's Conflicts of Interest at the Heart of the Opioid Epidemic : Interim Majority Staff Report. Committee on Oversight and Reform, U.S. House of Representatives, 2022.